CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol Cyclo for Treatment of Niemann-Pick Disease Type C [T-break Tech (Middle East)]

Press/Media: Press / Media

PeriodOct 6 2018

Media coverage

1

Media coverage

  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol Cyclo for Treatment of Niemann-Pick Disease Type C [T-break Tech (Middle East)]
    Media name/outletPharmacy Choice
    CountryUnited States
    Date10/6/18
    PersonsDarius Adams